Menu

A+ A A-

Download article

DOI: https://doi.org/10.22263/2312-4156.2016.3.69

Tikhonovskaya I.V., Adaskevich V.P., Myadelets V.O.
Cutaneous leishmaniasis: etiology, clinical picture, diagnosing, treatment
Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Vitebsk, Republic of Belarus

Vestnik VGMU. 2016;15(3):69-77.

Abstract.
The etiology, pathogenesis, clinical manifestations, diagnosis and treatment of cutaneous leishmaniasis are described in the article. This unusual for Belarus disease can be imported to the country by tourists, businessmen and people working at joint ventures. The cause of cutaneous leishmaniasis of the Old World is L. major or L. tropica, less frequently L. infantum, L. aethiopica. In the Mediterranean and the Caspian Seas region the cause of cutaneous leishmaniasis is L. infantum and L. chagasi. Cutaneous leishmaniasis of the New World is caused by L. mexicana, L. (L) amazonenesis, L. braziliensis, L. (V) panamensis, L (V) peruviana, and L. (V). guyanensis.
The clinical spectrum of cutaneous leishmaniasis includes localized, chronic recurrent, diffuse and acute forms. The applied methods of diagnosing are dermatoscopy, microscopy of bioptic material, smears, skin scrapings; culture on NNN medium, PCR and serological testing. Four types of histological manifestations are characteristic of leishmaniasis: I – abundant amastigotes; II – macrophages, polymorphonuclear neutrophils, plasma cells, necrosis; III – early granuloma with a focal accumulation of epithelioid cells, lymphocytes and a small number of plasma cells; IV – well-formed epithelioid granuloma within the derma with giant Langerhans cells, lymphocytes and epithelioid cells. The first line medicinal treatment options for cutaneous leishmaniasis are pentavalent antimony preparations: sodium stibogluconate intravenously or intramuscularly, meglumine antimoniate, intravenously or intramuscularly; oral miltefosine. The second line of therapy includes topical paramomycin, pentamidine intravenously or intramuscularly, oral fluconazole, liposomal amphotericin B or amphotericin B deoxycholate, allopurinol. Prevention of cutaneous leishmaniasis consists in patients’ informing, use of repellents, window insect screens and antimosquito bed nets.
Key words: cutaneous leishmaniasis, sodium stibogluconate, paramomycin, azoles.

References

1. Potekaev NS, Potekaev NN, Lvov AN, Ptashinskiy RI, Kochetkov MA, Lebedeva EV, Malyarenko EN, Sapozhnikova NA. Zoonoznyi kozhnyi leishmanioz: istoricheskii ekskurs i klinicheskoe nabliudenie [Zoonotic dermal leushmaniosis: historical digression and clinical observation]. Klin Dermatologiia Venerologiia. 2015;(5):41-50.
2. Pirmez C, Yamamura M, Uyemura K, Paes-Oliveira M, Conceição-Silva F, Modlin RL. Cytokine patterns in the pathogenesis of human leishmaniasis. J Clin Invest. 1993 Apr; 91(4):1390-5.
3. Murray HW, Berman JD, Davies CR, Saravia NG. Advances in leishmaniasis. Lancet. 2005 Oct-Nov;366(9496):1561-77.
4. Bari AU, Rahman SB. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol. 2008 Jan-Feb;74(1):23-7.
5. Mueller MC, Fleischmann E, Grunke M, Schewe S, Bogner JR, Löscher T. Relapsing Cutaneous leishmaniasis in a patient with ankylosing spondylitis treated with infliximab. Am J Trop Med Hyg. 2009 Jul;81(1):52-4.
6. Handler MZ, Patel PA, Kapila R, Al-Qubati Y, Schwartz RA. Cutaneous and mucocutaneous leishmaniasis: Differential diagnosis, diagnosis, histopathology, and management. J Am Acad Dermatol. 2015 Dec;73(6):911-26; 927-8.
7. Sokolova TV, Gladko VV, Safonov LA, Sokolova TV, red. Prakticheskie navyki v dermatovenerologii [Practical skills in a dermatovenerology]: sprav dlia vrachei. Moscow, RF: Meditsinskoe informatsionnoe agentstvo; 2011. 132 р.
8. de Vries HJ, Reedijk SH, Schallig HD. Cutaneous leishmaniasis: recent developments in diagnosis and management. Am J Clin Dermatol. 2015 Apr;16(2):99-109.
9. InBiOS: innovative diagnostics for infectious diseases [Internet]. 2016 [cited 2016 Fev 07]. Available from: http://www.inbios.com/rapid-tests/cl-detect-rapid-test.
10. Negi AK, Sharma NL, Mahajan VK, Ranjan N, Kanga AK. Comparative efficacy of intralesional sodium stibogluconate (SSG) alone and its combination with intramuscular SSG to treat localized cutaneous leishmaniasis: Results of a pilot study. Indian J Dermatol Venereol Leprol. 2007 Jul-Aug;73(4):280.
11. Monge-Maillo B, López-Vélez R. Therapeutic options for old world cutaneous leishmaniasis and new world cutaneous and mucocutaneous leishmaniasis. Drugs. 2013 Nov;73(17):1889-920.
12. Klinicheskie protokoly diagnostiki i lecheniia bol'nykh s bolezniami kozhi i podkozhnoi kletchatki [Clinical protocols of diagnostics and treatment of patients with illnesses of a skin and hypodermic fat] [Elektronnyi resurs]. Sait o meditsine, zdravookhranenii Belarusi i zdorovom obraze zhizni. Rezhim dostupa: http://minzdrav.gov.by/ru/static/spavochno-infirm/protololy_lechenia/protokoly_2008. Data dostupa: 15.06.2016.

Information about authors:
Tikhonovskaya I.V. – Candidate of Medical Sciences, associate professor of the Chair of Dermatovenerology, Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University»;
Adaskevich V.P. – Doctor of Medical Sciences, professor, head of the Chair of Dermatovenerology, Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University»;
Myadelets V.O. – Candidate of Medical Sciences, associate professor of the Chair of Dermatovenerology, Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University».

Correspondence address: Republic of Belarus, 210023, Vitebsk, 27 Frunze ave., Educational Establishment «Vitebsk State Order of Peoples’ Friendship Medical University», Chair of Dermatovenerology. E-mail: Этот адрес электронной почты защищён от спам-ботов. У вас должен быть включен JavaScript для просмотра. – Tikhonovskaya I.V.

Поиск по сайту